Takeda Pharmaceutical Company Limited (TAK) Reports Q3 EPS of JPY279.00

Takeda Pharmaceutical Company Limited (NYSE: TAK) reported Q3 EPS of JPY279.00. Revenue for the quarter came in at JPY2219.5 billion.

For earnings history and earnings-related data on Takeda Pharmaceutical Company Limited (TAK) click here.

You May Also Be Interested In

• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• Western Midstream prices $700M in senior notes due 2036
• Texas Capital Securities Downgrades Arcosa (ACA) to Hold